Coherus Oncology, Inc. (CHRS)
NASDAQ·Healthcare·Biotechnology
$1.33
-0.37%
Mkt Cap $211.67M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$6.02
Range $1.05 – $11.00
Implied Upside
+352.6%
Consensus $6.02 vs current $1.33
NASDAQ·Healthcare·Biotechnology
$1.33
-0.37%
Mkt Cap $211.67M
Buy
1
Hold
0
Sell
0
Price Target (4 analysts)
$6.02
Range $1.05 – $11.00
+352.6%
Consensus $6.02 vs current $1.33